Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,055 USD | +5,93% | +20,83% | +0,50% |
Attività
Numero di dipendenti: 89
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Proprietary Therapeutics
100,0
%
| 15 | 100,0 % | 24 | 100,0 % | +60,06% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 15 | 100,0 % | 24 | 100,0 % | +60,06% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
David Lennon
CEO | Chief Executive Officer | 53 | 02/10/23 |
Scott Giacobello
DFI | Director of Finance/CFO | 54 | 28/11/21 |
Neil Desai
CHM | Chairman | 59 | 01/10/11 |
Berta Grigorian
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/17 |
Loretta Itri
CTO | Chief Tech/Sci/R&D Officer | 74 | 25/10/21 |
Marcy Graham
IRC | Investor Relations Contact | 57 | 01/05/22 |
Raymond Steitz
HRO | Human Resources Officer | - | 01/06/22 |
Andrew Kwon
PRN | Corporate Officer/Principal | - | 01/01/19 |
Bryan Ball
PRN | Corporate Officer/Principal | 54 | 01/08/22 |
Stephen M. Rodin
LAW | General Counsel | 47 | 01/02/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Anupam Dalal
BRD | Director/Board Member | 52 | 26/08/21 |
Caley Castelein
CHM | Chairman | 53 | 26/08/21 |
Director/Board Member | 52 | 26/08/21 | |
Director/Board Member | 69 | 26/08/21 | |
Emma Reeve
BRD | Director/Board Member | 63 | 08/09/21 |
Mohammad Hirmand
BRD | Director/Board Member | 54 | 27/03/23 |
Neil Desai
CHM | Chairman | 59 | 01/10/11 |
Behzad Aghazadeh
BRD | Director/Board Member | 52 | 26/08/21 |
David Lennon
CEO | Chief Executive Officer | 53 | 02/10/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 24 554 205 | 19 866 312 ( 80,91 %) | 0 | 80,91 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+0,50% | 47,64 Mln | |
-3,93% | 86,16 Mrd | |
+2,76% | 40,17 Mrd | |
-17,00% | 31,47 Mrd | |
+54,44% | 25,24 Mrd | |
-12,14% | 15,82 Mrd | |
-9,12% | 11,96 Mrd | |
-15,10% | 11,89 Mrd | |
-42,56% | 11,61 Mrd | |
+4,87% | 8,84 Mrd |
- Borsa valori
- Azioni
- Azione AADI
- Società Aadi Bioscience, Inc.